Cheng Du Sheng Nuo Biotec Co.,Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cheng Du Sheng Nuo Biotec Co.,Ltd - overview
Established
2001
Location
Chengdu, Sichuan, China
Primary Industry
Biotechnology
About
Based in Chengdu, China and established in 2001, Cheng Du Sheng Nuo Biotec Co. ,Ltd is a biotech company that focuses the development of peptide drugs. In 2014, the company changed its name from Chengdu Shengnuo Technology Development to Cheng Du Sheng Nuo Biotec Co. ,Ltd.
In 2021, the company was listed on the Shanghai Stock Exchange. The company engages in the research and development of peptide drugs. Its main products include Atosiban Acetate Injection, Carbetocin Injection and Enfuvirtide for Injection. Enfuvirtide for injection is used to treat HIV-1 infected patients who have been treated with other antiretroviral drugs and still have HIV-1 virus replication.
Current Investors
YuanBio Venture, Tianyi Investment Group, Lepu Medical Technology (Beijing) Co., Ltd
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.snbiopharm.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.